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Introduction
Use of inhalation anesthetic sevoflurane has some
potential advantages over intravenous sedation in adult
survivors of cardiac arrest. Wake-up times are shorter
compared to intravenous sedation, neurologic assess-
ment could potentially be performed sooner and there
are reports of possible protection against ischaemic-
reperfusion injury. There are no prospective studies or
guidelines regarding use of sevoflurane in this setting.
Objectives
Our aim is to present a case series of adult survivors of
cardiac arrest who were sedated with sevoflurane.
Methods
We performed a retrospective, single-centre study in a
12-bed tertiary medical intensive care unit.
Results
Our cohort comprised 12 patients who were admitted
from November 2014 - April 2015. Mean age was 63.9 ±
14.9 years, 9 (75%) were men. Mean time from collapse to
return of spontaneous circulation was 13 ± 5 min. Mean
duration of sedation with sevoflurane was 2.5 ± 2.4days.
Five (42%) patients survived and 3 (25%) survived with
Cerebral Performance Category 1 and 2. We recorded no
self-extubations, one episode of unexpected awakening,
no new onset hyperkalemia and no QT prolongation.
Sevoflurane was discontinued in 2 (17%) patients because
of ventilation problems. Sevoflurane was used as the only
during therapeutic hypothermia in all patients and as the
only during mechanical ventilation sedative in 6 (50%)
patients. Propofol was used during mechanical ventilation
simultaneously in 4 (33%) patients and midazolam in
2 (17%) patients. Transient increase in liver function tests
was observed in 4 (33%) patients. In all cases it was attrib-
uted to ischaemic hepatitis and liver function normalized
within a week in all patients. Renal failure developed in
2 (17%) patients and was attributed to circulatory shock in
both patients.
Conclusions
Sedation with sevoflurane in adult survivors of cardiac
arrest was feasible and safe. Prospective trials are needed
to evaluate the role of sedation with sevoflurane in this
patient population.
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